Workflow
浙江东日(600113) - 2023 Q3 - 季度财报
ZJDRZJDR(SH:600113)2023-10-29 16:00

Financial Performance - Revenue for the third quarter was RMB 182,709,034.38, a decrease of 4.69% year-over-year[6] - Net profit attributable to shareholders was RMB 49,738,191.51, an increase of 25.18% year-over-year[6] - Basic earnings per share for the third quarter were RMB 0.12, an increase of 20.00% year-over-year[7] - Weighted average return on equity for the first nine months was 4.85%, a decrease of 0.8 percentage points year-over-year[7] - Total operating revenue for the first three quarters of 2023 was 528,224,880.52, a decrease from 738,841,687.03 in the same period of 2022[21] - Operating costs for the first three quarters of 2023 were 392,895,781.30, down from 541,449,154.31 in the same period of 2022[21] - Net profit for the first three quarters of 2023 was 91,530,593.69, compared to 148,710,950.24 in the same period of 2022[22] - Basic earnings per share for the first three quarters of 2023 were 0.26, down from 0.29 in the same period of 2022[23] Cash Flow and Liquidity - Operating cash flow for the first nine months was RMB 60,249,886.83, a decrease of 26.21% year-over-year[7] - Cash received from sales of goods and services in the first three quarters of 2023 was 590,485,289.82, up from 459,656,414.89 in the same period of 2022[25] - Net cash flow from operating activities for the first three quarters of 2023 was 60,249,886.83, down from 81,648,174.61 in the same period of 2022[26] - Net cash flow from investing activities for the first three quarters of 2023 was 338,290,172.49, a significant increase from -115,212,411.62 in the same period of 2022[26] - Total cash inflow from financing activities: 71,625,973.54[27] - Cash used for debt repayment: 61,865,000.00[27] - Cash used for dividends, profit distribution, or interest payments: 63,780,857.68[27] - Cash used for other financing activities: 10,150,226.18[27] - Total cash outflow from financing activities: 135,796,083.86[27] - Net cash flow from financing activities: -64,170,110.32[27] - Net increase in cash and cash equivalents: 334,369,949.00[27] - Beginning cash and cash equivalents balance: 604,611,260.31[27] - Ending cash and cash equivalents balance: 938,981,209.31[27] Assets and Liabilities - Total assets at the end of the reporting period were RMB 3,856,768,254.54, an increase of 34.98% compared to the end of the previous year[7] - The increase in total assets was mainly due to the inclusion of Shanxi Linfen Nongdu Company in the consolidated financial statements[10] - As of September 30, 2023, the company's total assets increased to RMB 3,856,768,254.54, up from RMB 2,857,330,340.14 at the end of 2022[17][20] - The company's monetary funds grew significantly to RMB 950,126,548.55 as of September 30, 2023, compared to RMB 588,566,162.81 at the end of 2022[17] - Inventory increased substantially to RMB 810,205,430.67 as of September 30, 2023, from RMB 107,957,331.43 at the end of 2022[17] - Total liabilities rose to RMB 1,431,097,996.12 as of September 30, 2023, compared to RMB 612,643,934.84 at the end of 2022[19][20] - The company's long-term loans increased to RMB 340,935,416.67 as of September 30, 2023, from RMB 1,501,240.71 at the end of 2022[19] - Retained earnings grew to RMB 1,364,011,560.59 as of September 30, 2023, up from RMB 1,306,988,384.98 at the end of 2022[20] Shareholder and Equity Information - The company's largest shareholder, Wenzhou Oriental Group Co., Ltd., holds 49.29% of the shares[13] - The top 10 shareholders hold a total of 62.09% of the company's shares[13] - The company completed the registration of the first grant of 10.1005 million restricted shares under the 2023 Restricted Stock Incentive Plan, with 95 eligible participants receiving shares at a price of RMB 3.72 per share[15][16] - The total capital raised from the restricted stock grant was RMB 37,573,860, with RMB 10,100,500 allocated as new registered capital and the remainder as capital reserve[16] - The company's registered capital increased to RMB 421,531,660 after the restricted stock grant, up from RMB 411,431,160[16][20] Expenses and Costs - R&D expenses for the first three quarters of 2023 were 6,561,221.14, up from 5,194,810.25 in the same period of 2022[21] - Sales expenses for the first three quarters of 2023 were 27,814,052.46, slightly up from 27,774,808.95 in the same period of 2022[21] - Management expenses for the first three quarters of 2023 were 45,312,595.17, up from 40,609,102.53 in the same period of 2022[21] Non-Recurring Items - Non-recurring gains and losses for the third quarter amounted to RMB 3,233,110.38[10]